Pay in 4 interest-free payments of $6.60 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Figure 3 In SGLT-Is RCTs (6 trials, 124 strokes, 31,327 participants), the risk of fatal hemorrhagic and ischemic stroke did not decrease with SGLT2-Is use (RR: 0.89, 95% CI [0.62, 1.28], p = 0.54) vs
Kathryn Wellen (University of Pennsylvania) for critical reading of our manuscript, Fran Vasquez for help with the CRISPR schematic, Uma Chandran and Jiefei Wang (UPMC Hillman Cancer Center Bioinformatics Core) for help with bioinformatic analysis of the CRISPR screen, and Maureen Lyons (UPMC Hillman Cancer Center Cancer Genomics Core) for help with sequencing of the CRISPR library
Our experience shows that the most successful protocols are those that pair an aggressive, results-driven active with a powerful, barrier-supportive ingredient
Fluorescence intensity and area of Rhodamine B were quantified relative to the total rectal area using Living Image 4.5 software (PerkinElmer, USA)
US$ 25.90
US$ 20.16
US$ 22.84
US$ 20.45
US$ 28.54
US$ 28.14
US$ 25.13
US$ 27.57
US$ 24.10
US$ 28.26
US$ 21.86
US$ 25.64
US$ 25.07
